UK's Recovery trial to continue testing Roche drug for COVID-19 – Reuters

UK’s Recovery trial to continue testing Roche drug for COVID-19 – Reuters

A major UK trial looking at whether some existing drugs may be used to treat COVID-19 is to continue testing Roche’s arthritis drug Actemra, also known as tocilizumab, despite separate trial results on Wednesday showing it had no benefit.

Read More…

You May Also Like